RPCONE
BIB icon

Retirement Planning Company of New England’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Retirement Planning Company of New England’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,366
Closed -$110K – 281
2021
Q4 		$110K Buy
+1,366
New +$117K 0.05% 291

Other funds holding BIB

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Retirement Planning Company of New England's BIB Position: Q1 2022 in Review

Retirement Planning Company of New England sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q1 2022, closing a stake of 1,366 shares — an estimated $110K sold.

Retirement Planning Company of New England first reported a position in BIB in Q4 2021 and held it in 1 quarter. The position peaked at $110K in Q4 2021. 28 funds tracked by Wall St. Rank hold BIB as of Q1 2022.

  • Retirement Planning Company of New England reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q1 2022 after selling out during the quarter.
  • Retirement Planning Company of New England sold 1,366 ProShares Ultra NASDAQ Biotechnology shares in Q1 2022, an estimated $110K.
  • Retirement Planning Company of New England first reported a position in ProShares Ultra NASDAQ Biotechnology in Q4 2021 and held it in 1 quarter.
  • Retirement Planning Company of New England's ProShares Ultra NASDAQ Biotechnology position peaked at $110K in Q4 2021.
  • 28 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q1 2022.

Based on Retirement Planning Company of New England's 13F filing for Q1 2022, filed 6 May 2022.